Is IMRT needed to spare the rectum when pelvic lymph nodes are part of the initial treatment volume for prostate cancer?

International Journal of Radiation Oncology Biology Physics

Volumn 64, Issue 1, 2006, Pages 151-160

  Sanguineti, Giuseppe ^a   Cavey, Matthew L ^a   Endres, Eugene J ^b   Brandon, Gunn G ^a   Bayouth, John E ^b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Dose escalation; Intensity modulated radiotherapy; Whole pelvis radiotherapy

Indexed keywords

DOSIMETRY; LOGISTICS; PROSTHETICS; REGRESSION ANALYSIS; TUMORS;

DOSE ESCALATION; INTENSITY-MODULATED RADIOTHERAPY; PLANNING TARGET VOLUME (PTV); WHOLE-PELVIS RADIOTHERAPY;

RADIOTHERAPY;

CLINICAL ARTICLE; CONFERENCE PAPER; DATA BASE; DOSIMETRY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; ORGAN SIZE; PELVIS LYMPH NODE; PREDICTION; PRESCRIPTION; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RECTUM;

CHI-SQUARE DISTRIBUTION; HUMANS; LYMPH NODES; MALE; PELVIS; PROSTATIC NEOPLASMS; RADIATION DOSAGE; RADIATION INJURIES; RADIATION PROTECTION; RADIOTHERAPY, INTENSITY-MODULATED; RECTUM; REGRESSION ANALYSIS;

EID: 29244432167     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2005.06.026     Document Type: Conference Paper

References (39)

1. M.J. Zelefsky, J. Moughan, J. Owen Changing trends in national practice for external beam radiotherapy for clinically localized prostate cancer 1999 Patterns of Care survey for prostate cancer Int J Radiat Oncol Biol Phys 59 2004 1053 1061
2. M. Roach 3rd, M. DeSilvio, C. Lawton Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression Radiation Therapy Oncology Group 9413 J Clin Oncol 21 2003 1904 1911
3. A. Pollack A call for more with a desire for less Pelvic radiotherapy with androgen deprivation in the treatment of prostate cancer J Clin Oncol 21 2003 1899 1901
4. J.D. Forman, Y. Lee, P. Roberson Advantages of CT and beam's eye view display to confirm the accuracy of pelvic lymph node irradiation in carcinoma of the prostate Radiology 186 1993 889 892
5. M. Roach, M. DeSilvio, C.R. Thomas Progression free survival (PFS) after whole-pelvic (WP) vs. mini-pelvic (MP) or prostate only (PO) radiotherapy (RT): A subset analysis of RTOG 9413, a phase III prospective randomized trial using neoadjuvant and concurrent (N&CHT) Int J Radiat Oncol Biol Phys 60 2004 S264 S265 [abstract]
6. G. Luxton, S.L. Hancock, A.L. Boyer Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate Int J Radiat Oncol Biol Phys 59 2004 267 284
7. M.L. Cavey, J.E. Bayouth, M. Colman IMRT to treat the pelvic nodes while escalating the dose to the prostate Strahlenther Onkol 181 2005 431 441
8. C.M. Nutting, D.J. Convery, V.P. Cosgrove Reduction of small and large bowel irradiation using an optimized intensity-modulated pelvic radiotherapy technique in patients with prostate cancer Int J Radiat Oncol Biol Phys 48 2000 649 656
9. K.S. Chao, M. Lin Lymphangiogram-assisted lymph node target delineation for patients with gynecologic malignancies Int J Radiat Oncol Biol Phys 54 2002 1147 1152
10. C. Fiorino, V. Vavassori, G. Sanguineti Rectum contouring variability in patients treated for prostate cancer Impact on rectum dose-volume histograms and normal tissue complication probability Radiother Oncol 63 2002 249 255
11. G.H. Fletcher Textbook of radiotherapy 1980 Lea & Febinger Philadelphia
12. C. Fiorino, G. Sanguineti, C. Cozzarini Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer Int J Radiat Oncol Biol Phys 57 2003 953 962
13. E.H. Huang, A. Pollack, L. Levy Late rectal toxicity Dose-volume effects of conformal radiotherapy for prostate cancer Int J Radiat Oncol Biol Phys 54 2002 1314 1321
14. J.M. Michalski, K. Winter, J.A. Purdy Trade-off to low-grade toxicity with conformal radiation therapy for prostate cancer on Radiation Therapy Oncology Group 9406 Semin Radiat Oncol 12 2002 75 80
15. G. Sanguineti, L. Culp, J. Pena Acute small bowel and colon toxicity after pelvic IMRT for prostate cancer Eur J Cancer Suppl 1 2003 S268 [abstract]
16. G. Bauman, G. Rodrigues In regard to Fiorino, et al.: Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer Int J Radiat Oncol Biol Phys 59 2004 912 914
17. J. Zhang, K.F. Yu What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes JAMA 280 1998 1690 1691
18. T.M. Pisansky, R.W. Lee, C.A. Lawton Prostate cancer L.J. Gunderson J.E. Tepper Clinical radiation oncology 2000 Churchill Livingstone Philadelphia
19. T. Roberts, M. Roach 3rd The evolving role of pelvic radiation therapy Semin Radiat Oncol 13 2003 109 120
20. C.A. Perez, M.V. Pilepich, D. Garcia Definitive radiation therapy in carcinoma of the prostate localized to the pelvis Experience at the Mallinckrodt Institute of Radiology NCI Monogr 7 1988 85 94
21. M.K. Buyyounouski, E.M. Horwitz, R.A. Price Intensity-modulated radiotherapy with MRI simulation to reduce doses received by erectile tissue during prostate cancer treatment Int J Radiat Oncol Biol Phys 58 2004 743 749
22. S.L. Tucker, L. Dong, R. Cheung Comparison of rectal dose-wall histogram versus dose-volume histogram for modeling the incidence of late rectal bleeding after radiotherapy Int J Radiat Oncol Biol Phys 60 2004 1589 1601
23. D. Kuban, A. Pollack, E. Huang Hazards of dose escalation in prostate cancer radiotherapy Int J Radiat Oncol Biol Phys 57 2003 1260 1268
24. S.T. Peeters, W.D. Heemsbergen, W.L. van Putten Acute and late complications after radiotherapy for prostate cancer Results of a multicenter randomized trial comparing 68 Gy to 78 Gy Int J Radiat Oncol Biol Phys 61 2005 1019 1034
25. C. Fiorino, C. Cozzarini, V. Vavassori Relationships between DVHs and late rectal bleeding after radiotherapy for prostate cancer Analysis of a large group of patients pooled from three institutions Radiother Oncol 64 2002 1 12
26. T. Rancati, C. Fiorino, G. Gagliardi Fitting late rectal bleeding data using different NTCP models Results from an Italian multi-centric study (AIROPROS0101) Radiother Oncol 73 2004 21 32
27. E. Dale, D.R. Olsen, S.D. Fossa Normal tissue complication probabilities correlated with late effects in the rectum after prostate conformal radiotherapy Int J Radiat Oncol Biol Phys 43 1999 385 391
28. S. Wachter, N. Gerstner, G. Goldner Rectal sequelae after conformal radiotherapy of prostate cancer Dose-volume histograms as predictive factors Radiother Oncol 59 2001 65 70
29. L.J. Bos, E.M. Damen, R.W. de Boer Reduction of rectal dose by integration of the boost in the large-field treatment plan for prostate irradiation Int J Radiat Oncol Biol Phys 52 2002 254 265
30. S.A. Leibel, Z. Fuks, M.J. Zelefsky Technological advances in external-beam radiation therapy for the treatment of localized prostate cancer Semin Oncol 30 2003 596 615
31. D.B. Chism, E.M. Horwitz, A.L. Hanlon Late morbidity profiles in prostate cancer patients treated to 79-84 Gy by a simple four-field coplanar beam arrangement Int J Radiat Oncol Biol Phys 55 2003 71 77
32. S.J. Feigenberg, A.L. Hanlon, E.M. Horwitz What pretreatment prostate-specific antigen level warrants long-term androgen deprivation? Int J Radiat Oncol Biol Phys 61 2005 1003 1010
33. P. Bader, F.C. Burkhard, R. Markwalder Is a limited lymph node dissection an adequate staging procedure for prostate cancer? J Urol 168 2002 514 518
34. A. Heidenreich, Z. Varga, R. Von Knobloch Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy High incidence of lymph node metastasis J Urol 167 2002 1681 1686
35. M. Golimbu, J. Provet, S. Al-Askari Radical prostatectomy for stage D1 prostate cancer. Prognostic variables and results of treatment Urology 30 1987 427 435
36. M.E. Allaf, G.S. Palapattu, B.J. Trock Anatomical extent of lymph node dissection Impact on men with clinically localized prostate cancer J Urol 172 2004 1840 1844
37. C.C. Pan, K.Y. Kim, J.M. Taylor Influence of 3D-CRT pelvic irradiation on outcome in prostate cancer treated with external beam radiotherapy Int J Radiat Oncol Biol Phys 53 2002 1139 1145
38. S.A. Leibel ACR appropriateness criteria. Expert Panel on Radiation Oncology. American College of Radiology Int J Radiat Oncol Biol Phys 43 1999 125 168
39. R. Jacob, A.L. Hanlon, E.M. Horwitz Role of prostate dose escalation in patients with greater than 15% risk of pelvic lymph node involvement Int J Radiat Oncol Biol Phys 61 2005 695 701